No Cover Image

Journal article 199 views 16 downloads

Olympic Doping, Transparency, and the Therapeutic Exemption Process / Luke Cox; Andrew Bloodworth; Michael McNamee

Diagoras, Volume: 1, Pages: 55 - 74

Swansea University Author: McNamee, Michael

Abstract

Within anti-doping policy, the Therapeutic Use Exemption policy enables athletes with a range of medical conditions to compete within elite sport even after receiving prohibited medication substances or methods. It has been claimed, however, that the policy is being misused as a means to enhancing p...

Full description

Published in: Diagoras
ISSN: 2565-196X
Published:
Online Access: Check full text

URI: https://cronfa.swan.ac.uk/Record/cronfa36798
Tags: Add Tag
No Tags, Be the first to tag this record!
first_indexed 2017-11-16T20:20:00Z
last_indexed 2018-02-09T05:29:29Z
id cronfa36798
recordtype SURis
fullrecord <?xml version="1.0"?><rfc1807><datestamp>2018-01-03T09:44:08Z</datestamp><bib-version>v2</bib-version><id>36798</id><entry>2017-11-16</entry><title>Olympic Doping, Transparency, and the Therapeutic Exemption Process</title><alternativeTitle></alternativeTitle><author>Michael McNamee</author><firstname>Michael</firstname><surname>McNamee</surname><active>true</active><ORCID>0000-0002-5857-909X</ORCID><ethesisStudent>false</ethesisStudent><sid>85b0b1623e55d977378622a6aab7ee6e</sid><email>b21656b4e9823fba622ff78b66e2d5d4</email><emailaddr>SQWVRrxFk2ozzjXfmS4VKBXCE6Z9OGBXOD9D5JU4+T4=</emailaddr><date>2017-11-16</date><deptcode>STSC</deptcode><abstract>Within anti-doping policy, the Therapeutic Use Exemption policy enables athletes with a range of medical conditions to compete within elite sport even after receiving prohibited medication substances or methods. It has been claimed, however, that the policy is being misused as a means to enhancing performance in healthy athletes, or athletes who do not suffer from a relevant pathological condition. To counter misuse of TUEs, it has claimed that the data captured in the TUE process should be transparent, even though this would reveal medical information concerning the athlete that would normally be thought of as private. There are further concerns regarding the sharing of medical data within sports organisations, between medical professionals and performance directors or coaches. We critically explore the TUE process, and argue against proposals for a transparent TUE policy on grounds of privacy and concerns for athlete welfare .We conclude that the notion of sports integrity, the threat of doping, and the extension of anti-doping policy, need to be considered within a broader context that also concerns the goals of sports medicine and athlete welfare.</abstract><type>Journal article</type><journal>Diagoras</journal><volume>1</volume><journalNumber/><paginationStart>55</paginationStart><paginationEnd>74</paginationEnd><publisher></publisher><placeOfPublication/><isbnPrint/><isbnElectronic/><issnPrint/><issnElectronic>2565-196X</issnElectronic><keywords>Doping, Ethics, Privacy, Transparency, Sports medicine, Data sharing</keywords><publishedDay>0</publishedDay><publishedMonth>0</publishedMonth><publishedYear>0</publishedYear><publishedDate>0001-01-01</publishedDate><doi></doi><url>http://www.diagorasjournal.com/index.php/diagoras/article/view/8</url><notes></notes><college>College of Engineering</college><department>Sports Science</department><CollegeCode>CENG</CollegeCode><DepartmentCode>STSC</DepartmentCode><institution/><researchGroup>None</researchGroup><supervisor/><sponsorsfunders/><grantnumber/><degreelevel/><degreename>None</degreename><lastEdited>2018-01-03T09:44:08Z</lastEdited><Created>2017-11-16T13:12:44Z</Created><path><level id="1">College of Engineering</level><level id="2">Engineering</level></path><authors><author><firstname>Luke</firstname><surname>Cox</surname><orcid/><order>1</order></author><author><firstname>Andrew</firstname><surname>Bloodworth</surname><orcid/><order>2</order></author><author><firstname>Michael</firstname><surname>McNamee</surname><orcid/><order>3</order></author></authors><documents><document><filename>0036798-16112017131523.pdf</filename><originalFilename>cox2017v2.pdf</originalFilename><uploaded>2017-11-16T13:15:23Z</uploaded><type>Output</type><contentLength>4114249</contentLength><contentType>application/pdf</contentType><version>VoR</version><cronfaStatus>true</cronfaStatus><action>Published to Cronfa</action><actionDate>11/12/2017</actionDate><embargoDate>2017-11-16T00:00:00</embargoDate><documentNotes/><copyrightCorrect>false</copyrightCorrect><language>eng</language></document></documents></rfc1807>
spelling 2018-01-03T09:44:08Z v2 36798 2017-11-16 Olympic Doping, Transparency, and the Therapeutic Exemption Process Michael McNamee Michael McNamee true 0000-0002-5857-909X false 85b0b1623e55d977378622a6aab7ee6e b21656b4e9823fba622ff78b66e2d5d4 SQWVRrxFk2ozzjXfmS4VKBXCE6Z9OGBXOD9D5JU4+T4= 2017-11-16 STSC Within anti-doping policy, the Therapeutic Use Exemption policy enables athletes with a range of medical conditions to compete within elite sport even after receiving prohibited medication substances or methods. It has been claimed, however, that the policy is being misused as a means to enhancing performance in healthy athletes, or athletes who do not suffer from a relevant pathological condition. To counter misuse of TUEs, it has claimed that the data captured in the TUE process should be transparent, even though this would reveal medical information concerning the athlete that would normally be thought of as private. There are further concerns regarding the sharing of medical data within sports organisations, between medical professionals and performance directors or coaches. We critically explore the TUE process, and argue against proposals for a transparent TUE policy on grounds of privacy and concerns for athlete welfare .We conclude that the notion of sports integrity, the threat of doping, and the extension of anti-doping policy, need to be considered within a broader context that also concerns the goals of sports medicine and athlete welfare. Journal article Diagoras 1 55 74 2565-196X Doping, Ethics, Privacy, Transparency, Sports medicine, Data sharing 0 0 0 0001-01-01 http://www.diagorasjournal.com/index.php/diagoras/article/view/8 College of Engineering Sports Science CENG STSC None None 2018-01-03T09:44:08Z 2017-11-16T13:12:44Z College of Engineering Engineering Luke Cox 1 Andrew Bloodworth 2 Michael McNamee 3 0036798-16112017131523.pdf cox2017v2.pdf 2017-11-16T13:15:23Z Output 4114249 application/pdf VoR true Published to Cronfa 11/12/2017 2017-11-16T00:00:00 false eng
title Olympic Doping, Transparency, and the Therapeutic Exemption Process
spellingShingle Olympic Doping, Transparency, and the Therapeutic Exemption Process
McNamee, Michael
title_short Olympic Doping, Transparency, and the Therapeutic Exemption Process
title_full Olympic Doping, Transparency, and the Therapeutic Exemption Process
title_fullStr Olympic Doping, Transparency, and the Therapeutic Exemption Process
title_full_unstemmed Olympic Doping, Transparency, and the Therapeutic Exemption Process
title_sort Olympic Doping, Transparency, and the Therapeutic Exemption Process
author_id_str_mv 85b0b1623e55d977378622a6aab7ee6e
author_id_fullname_str_mv 85b0b1623e55d977378622a6aab7ee6e_***_McNamee, Michael
author McNamee, Michael
author2 Luke Cox
Andrew Bloodworth
Michael McNamee
format Journal article
container_title Diagoras
container_volume 1
container_start_page 55
institution Swansea University
issn 2565-196X
college_str College of Engineering
hierarchytype
hierarchy_top_id collegeofengineering
hierarchy_top_title College of Engineering
hierarchy_parent_id collegeofengineering
hierarchy_parent_title College of Engineering
department_str Engineering{{{_:::_}}}College of Engineering{{{_:::_}}}Engineering
url http://www.diagorasjournal.com/index.php/diagoras/article/view/8
document_store_str 1
active_str 1
description Within anti-doping policy, the Therapeutic Use Exemption policy enables athletes with a range of medical conditions to compete within elite sport even after receiving prohibited medication substances or methods. It has been claimed, however, that the policy is being misused as a means to enhancing performance in healthy athletes, or athletes who do not suffer from a relevant pathological condition. To counter misuse of TUEs, it has claimed that the data captured in the TUE process should be transparent, even though this would reveal medical information concerning the athlete that would normally be thought of as private. There are further concerns regarding the sharing of medical data within sports organisations, between medical professionals and performance directors or coaches. We critically explore the TUE process, and argue against proposals for a transparent TUE policy on grounds of privacy and concerns for athlete welfare .We conclude that the notion of sports integrity, the threat of doping, and the extension of anti-doping policy, need to be considered within a broader context that also concerns the goals of sports medicine and athlete welfare.
published_date 0001-01-01T12:49:22Z
_version_ 1631152412930605056
score 10.801898